Doyle Mittie Insider Trading Activity
Doyle Mittie has been net-selling over the last 12 months with 0 purchases and 10 sales across 1 company.
AVTX is the most-traded position with 10 trades. The largest single transaction was a sale of AVTX for $953K on May 6, 2026.
Performance Scorecard
Forward stock performance after each transaction by Doyle Mittie. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +24.1% | 89% | 9 |
| 90 days | — | — | — | — |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersAVTX · Avalo Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Doyle Mittie bought and sold AVTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| May 15, 2026 | AVTX | Sell | 3,000 | $18.76 | $56K | Chief Medical Officer |
| May 6, 2026 | AVTX | Sell | 27,538 | $18.03 | $496K | Chief Medical Officer |
| May 6, 2026 | AVTX | Sell | 5,000 | $19.65 | $98K | Chief Medical Officer |
| May 6, 2026 | AVTX | Sell | 44,944 | $21.20 | $953K | Chief Medical Officer |
| May 6, 2026 | AVTX | Sell | 19,015 | $22.41 | $426K | Chief Medical Officer |
| May 6, 2026 | AVTX | Sell | 10,058 | $22.88 | $230K | Chief Medical Officer |
| May 5, 2026 | AVTX | Sell | 1,679 | $16.00 | $27K | Chief Medical Officer |
| Apr 6, 2026 | AVTX | Sell | 3,970 | $18.01 | $72K | Chief Medical Officer |
| Apr 1, 2026 | AVTX | Sell | 679 | $16.00 | $11K | Chief Medical Officer |
| Mar 16, 2026 | AVTX | Sell | 25,492 | $16.15 | $412K | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 10 | $2.8M |
Other insiders at Avalo Therapeutics, Inc.
2 other tracked filers at AVTX.